EUVIMED · CrossrefJournal
Neuromuscular Disorders
ISSN 0960-8966 · Elsevier BV
Latest articles
Interindividual variability of muscle involvement on imaging in a family with FLNC c.577G>A (p.A193T)-related myopathy
Book Review
Non-invasive assessment of microvascular changes in a Duchenne muscular dystrophy rat model with near-infrared spectroscopy
Meeting report on the 2nd clinical and scientific conference on ADSS1 myopathy. 24 October 2025, Boston Children’s Hospital, Brookline, Massachusetts, United States of America
Expanding the clinical and genetic spectrum of biallelic MYO18B pathogenic variants in congenital myopathy
Facioscapulohumeral muscular dystrophy: revisiting three prevailing assumptions through the perspective of FSHD Europe
Longitudinal riboflavin response in homozygous SLC52A2 p.Pro134Leu: a Turkish kindred with riboflavin transporter deficiency type 2
Clinical associations of pain in an international facioscapulohumeral muscular dystrophy cohort
Chronological patterns of pathogenic variant distributions in muscular dystrophy genes
Nocturnal sleep abnormalities occur before motor function deterioration in early-treated patients with infantile-onset Pompe disease: a two-decade newborn screening cohort study
Lower urinary tract dysfunction in adults with myotonic dystrophy type 1: a multimodal clinical assessment
Nemaline myopathy patient and caregiver perspectives: a multinational cross-sectional study
TTN-related limb-girdle muscular dystrophy caused by a homozygous c.107837A>C variant: first report in an African patient
Erratum to “Expression of genetic peripheral neuropathies in South African children” [Neuromuscular Disorders, 59 (2026): 106283]
Exercise training in adults with neuromuscular diseases: insights from two global surveys of lived experience and clinical practice
291st ENMC International Workshop: Optimizing Collaborative Models in Neuromuscular Diseases: The Role of Ontologies and Artificial Intelligence. Hoofddorp, The Netherlands, 16-18 January 2026
Opportunistic Muscle Biomarkers Derived from Dual-Energy Computed Tomography in Amyotrophic Lateral Sclerosis
How Effective Is Presymptomatic Treatment? Longitudinal Real-World Outcomes with Nusinersen in Spinal Muscular Atrophy Patients with Two SMN2 Copies
Clinical-epidemiological profile and motor function data of patients with Spinal Muscular Atrophy and four or more copies of SMN2
Editorial Board
WMS General Information
ENMC Themed Workshops, call
Congenital myasthenic syndromes in Türkiye: genetic and clinical spectrum revisited in a nationwide pediatric cohort
Integrating EMG and plasma biomarkers to characterize neuromuscular remodeling in sarcopenia
Comparison of Training Pathways for Certifying Clinical Evaluators of Charcot-Marie-Tooth Disease and Related Neuropathies
Baseline characterisation of adults living with spinal muscular atrophy in the UK: insight from the Adult SMA REACH Real-World Data Collection Study
Longitudinal functional trajectories in Duchenne muscular dystrophy: outcome-specific patterns from a registry-based modelling study
A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatment
Clinical studies in 82 individuals with valosin-containing protein (VCP) associated multisystem proteinopathy and literature review
Severe dilated cardiomyopathy in females with dystrophinopathy : a case series of nine patients
Volumes
2026 · 1,0612025 · 9012024 · 9212023 · 6732022 · 5582021 · 5662020 · 5192019 · 7432018 · 7182017 · 8722016 · 6182015 · 6492014 · 6782013 · 5302012 · 6492011 · 6412010 · 5702009 · 5612008 · 5622007 · 6632006 · 4812005 · 1742004 · 1812003 · 1562002 · 2092001 · 1332000 · 1191999 · 1011998 · 1041997 · 3271996 · 3941995 · 1081994 · 2091993 · 1241992 · 911991 · 106
EUVIMED